Downregulation of ACE2 is associated with advanced pathological features and poor prognosis in clear cell renal cell

Tianjiao Wang1, Fang Xie2, Yun-Hui Li3

  • 1Bioinformatics Department, Key Laboratory of Cell Biology, Ministry of Public Health & Key Laboratory of Medical Cell Biology, Ministry of Education, School of Life Sciences, China Medical University, Shenyang 110122, China.

Insights

Angiotensin-converting enzyme 2 (ACE2) expression is altered in clear cell renal cell carcinoma (ccRCC). Lower ACE2 levels correlate with poor prognosis and are linked to immune cell infiltration in ccRCC.

Area of Science:

  • Oncology
  • Genomics
  • Immunology

Background:

  • Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer.
  • The role of Angiotensin-converting enzyme 2 (ACE2) in ccRCC development and progression is not fully understood.
  • Tumor microenvironment and immune cell infiltration are critical factors in ccRCC pathogenesis.

Purpose of the Study:

  • To investigate alterations in ACE2 gene expression in ccRCC.
  • To explore the correlation between ACE2 expression and immune cell infiltration within the ccRCC tumor microenvironment.
  • To evaluate the prognostic value of ACE2 in ccRCC patients.

Main Methods:

  • Analysis of ACE2 expression profiles and prognostic significance using The Cancer Genome Atlas (TCGA) database.
  • Application of ESTIMATE and CIBERSORT algorithms to assess the relationship between ACE2 expression and immune cell subtypes.
  • Correlation analysis of ACE2 expression with clinical parameters including sex, metastasis, stage, and grade.

Main Results:

  • ACE2 expression levels were significantly correlated with sex, distant metastasis, clinical stage, tumor T stage, and histological grade.
  • Downregulation of ACE2 was associated with an unfavorable prognosis in ccRCC patients.
  • ACE2 expression demonstrated a significant association with various immune cell subtypes within the tumor microenvironment.

Conclusions:

  • ACE2 plays a significant role in the development and progression of ccRCC.
  • ACE2 expression is linked to immune cell infiltration and clinical characteristics of ccRCC.
  • ACE2 may serve as a valuable prognostic biomarker for ccRCC patients.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
1.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
569
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.3K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
903
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K